CERo Therapeutics Holdings, Inc. (CERO)
OTCMKTS · Delayed Price · Currency is USD
0.0060
-0.000377 (-5.91%)
At close: Oct 16, 2026
CERo Therapeutics Holdings Employees
CERo Therapeutics Holdings had 8 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes CERo Therapeutics Holdings the 40,759th largest employer in the world and 6,192nd in the United States.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
455.53K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 8 | 0 | - | 8 | 0 |
| Dec 31, 2024 | 8 | -1 | -11.11% | 8 | 0 |
| Dec 31, 2023 | 9 | - | - | 8 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Orgenesis | 77 |
| Lyra Therapeutics | 27 |
| Altamira Therapeutics | 11 |
| ZyVersa Therapeutics | 6 |
| Actavia Life Sciences | 1 |
| CNBX Pharmaceuticals | 1 |
CERo Therapeutics Holdings News
- 4 months ago - CERo Therapeutics Announces Clinical Update from CERTAIN-T Phase 1 CER-1236 Trial, Including Patient Undergoing Allogeneic Stem Cell Transplant Following Treatment - GlobeNewsWire
- 5 months ago - CERo Therapeutics Completes Second Ascending Dose Cohort of Phase 1 CER-1236 Trial - GlobeNewsWire
- 6 months ago - CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial - GlobeNewsWire
- 6 months ago - CERo Therapeutics Doses Second Patient in Cohort 2 of Phase 1 CER-1236 Trial - GlobeNewsWire
- 7 months ago - Cero Therapeutics issues letter to shareholders - TheFly
- 7 months ago - CERo Therapeutics Provides Shareholder Update - GlobeNewsWire
- 8 months ago - Cero Therapeutics appoints Eric Francois to board of directors - TheFly
- 8 months ago - CERo Therapeutics Announces Biotech Industry Veteran Eric Francois to Join its Board of Directors - GlobeNewsWire